GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 768 filers reported holding GLAXOSMITHKLINE PLC in Q4 2017. The put-call ratio across all filers is 1.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $22,000 | -8.3% | 607 | +5.2% | 0.01% | -25.0% |
| Q2 2020 | $24,000 | +9.1% | 577 | 0.0% | 0.01% | -11.1% |
| Q1 2020 | $22,000 | -18.5% | 577 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $27,000 | -78.0% | 577 | -80.0% | 0.01% | -79.1% |
| Q3 2019 | $123,000 | +7.0% | 2,880 | +0.1% | 0.04% | 0.0% |
| Q2 2019 | $115,000 | -16.1% | 2,878 | -12.1% | 0.04% | -25.9% |
| Q1 2019 | $137,000 | +9.6% | 3,276 | +0.1% | 0.06% | -10.8% |
| Q4 2018 | $125,000 | -53.9% | 3,274 | -51.4% | 0.06% | -48.0% |
| Q3 2018 | $271,000 | -50.2% | 6,743 | -50.1% | 0.12% | -58.7% |
| Q2 2018 | $544,000 | -4.4% | 13,504 | -7.4% | 0.30% | -10.1% |
| Q1 2018 | $569,000 | +505.3% | 14,583 | +446.8% | 0.34% | +395.6% |
| Q4 2017 | $94,000 | – | 2,667 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |